Don Whitley Scientific Ltd (DWS) has announced a new venture into the tissue engineering and regenerative medicine market having signed an exclusive distributor agreement with Spanish biotechnology company, Ebers Medical Technology, to sell its systems in the UK.
According to industry analysis company Medmarket Diligence*, the largest market for tissue engineered products is the ‘replacement of structurally or physiologically deficient or diseased tissues and organs in humans’. However, the NHS website ‘Give and Let Live’ states that only a third of people who need an organ transplant actually receive one. This doesn’t even include the statistics for those people needing tissue transplantation, a report said.
The agreement with Ebers Medical, which will see DWS introduce the TEB1000 Master Unit tissue processing system into the UK, also includes distribution of the products in Germany and Australia by DWS subsidiary companies, Meintrup-DWS Laborgeräte GmbH and Don Whitley Scientific PTY.
Managing Director of DWS, Paul Walton, commented:
“This is an exciting product for a relatively young but very important market. Our long history of providing solutions to scientists will help us bring this innovation to tissue engineering specialists who are already making a difference in medicine today.”
*Tissue Engineering, Cell Therapy & Transplantation: Products, technologies & Market Opportunities Worldwide, 2009-2018 (Jan 2010)